Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Lynparza improved median time patients lived without disease progression to over four and half years in BRCA-mutated advanced ovarian cancer vs. just over one year with placebo
-
Imfinzi demonstrated unprecedented survival in unresectable, Stage III non-small cell lung cancer with an estimated 50% of patients surviving four years
-
AstraZeneca acquires oral PCSK9 inhibitor programme from Dogma Therapeutics
-
COVID-19 vaccine AZD1222 clinical trials resumed in the UK
-
AstraZeneca to list US ADR equity and all US debt securities on Nasdaq
-
Fasenra met both co-primary endpoints of reduced nasal polyp size and blockage in the OSTRO Phase III trial for patients with chronic rhinosinusitis with nasal polyps
-
Statement on AstraZeneca Oxford SARS-CoV-2 vaccine, AZD1222, COVID-19 vaccine trials temporary pause
-
Biopharma leaders unite to stand with science
-
AstraZeneca aims to transform cancer treatment and advance clinical practice with data presented at ESMO 2020
-
New analyses from Breztri Aerosphere Phase III ETHOS trial to be presented at the European Respiratory Society International Congress 2020
Latest articles and press releases
All of our latest press releases and articles are available to explore
